About the Company
We do not have any company description for Caribou Biosciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Caribou Biosciences, Inc.
Caribou Biosciences, Inc. Announces Strategic Pipeline ... - Nasdaq
Caribou Biosciences, Inc. announced a strategic shift focusing on its lead oncology programs, CB-010 and CB-011, involving workforce and cost reductions aimed at extending its cash runway into the ...
Caribou Biosciences, Inc. Class Action: Levi & Korsinsky Reminds ...
Provided by PR NewswireFeb 11, 2025 10:45am Caribou Biosciences, Inc. Class Action: Levi & Korsinsky Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead ...
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
Two robust clinical datasets from CB-010 and CB-011 expected to be disclosed in H2 2025 -- -- $184 million in cash, cash equivalents, and marketable securities expected to fund the Company’s current ...
Caribou Biosciences, Inc. Sued for Securities Law Violations ...
THE LAWSUIT: A class action securities lawsuit was filed against Caribou Biosciences, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud ...
Caribou Biosciences, Inc. Class Action: The Gross Law Firm Reminds ...
PR Newswire NEW YORK, Feb. 20, 2025 NEW YORK, Feb. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU).
Class Action Filed Against Caribou Biosciences, Inc. (CRBU) - February ...
THE LAWSUIT: A class action securities lawsuit was filed against Caribou Biosciences, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud ...
Intech Investment Management LLC Increases Position in Caribou ...
Intech Investment Management LLC increased its stake in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 69.4% in the fourth quarter, according to its most recent 13F filing ...
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue ...
Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.43 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.46 per share a year ago.
Class Action Filed Against Caribou Biosciences, Inc. (CRBU) - February ...
Class Action Filed Against Caribou Biosciences, Inc. (CRBU) - February 24, 2025 Deadline to Join - Contact Levi & Korsinsky PRESS RELEASE ACCESS Newswire Feb. 10, 2025, 07:30 AM ...
Caribou Biosciences, Inc. Sued for Securities Law Violations - Contact ...
NEW YORK, Feb. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU). Shareholders who purchased shares of CRBU during ...
Similar Companies
Loading the latest forecasts...